Clinical Trials on Immune Deficiency Disease in New Zealand
Total 43872 results
-
CSL LimitedCompletedPrimary Immune DeficiencyAustralia, New Zealand
-
Swiss Federal Institute of TechnologyCompletedPregnancy Related | Iodine DeficiencyNew Zealand
-
Arcturus Therapeutics, Inc.CompletedOrnithine Transcarbamylase DeficiencyNew Zealand
-
Dicerna Pharmaceuticals, Inc.WithdrawnAlpha 1-Antitrypsin DeficiencyNew Zealand
-
Arrowhead PharmaceuticalsCompleted
-
Intellia TherapeuticsNot yet recruitingHereditary AngioedemaFrance, New Zealand, United Kingdom
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyCompleted
-
Alexion PharmaceuticalsSyneos HealthTerminated
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisNew Zealand, Australia
-
Resistentia Pharmaceuticals ABCompleted
-
Rochester General HospitalCompletedSecondary Immune DeficiencyUnited States
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
-
ViiV HealthcareCompletedHIV InfectionsUnited States, New Zealand
-
Insulet CorporationCompleted
-
University of OtagoCompleted
-
Arrowhead PharmaceuticalsRecruitingIgA NephropathyNew Zealand
-
Tavotek BiotherapeuticsRecruiting
-
Diatranz Otsuka LimitedCompleted
-
Edgar National Centre for Diabetes ResearchCompletedInsulin ResistanceNew Zealand
-
Rochester General HospitalCompletedSecondary Immune Deficiency DisorderUnited States
-
Gilead SciencesCompletedHIVUnited States, New Zealand
-
Intellia TherapeuticsActive, not recruitingHereditary AngioedemaFrance, New Zealand, Germany, United Kingdom, Netherlands, Australia
-
Murdoch Childrens Research InstituteRoyal Children's HospitalCompletedPrimary Immunodeficiency | Invasive Pneumococcal Disease, Protection Against | Invasive Pneumococcal Disease, Recurrent Isolated, 1 | Invasive Pneumococcal Disease, Recurrent Isolated, 2Australia, New Zealand
-
Icahn School of Medicine at Mount SinaiRecruitingAutoimmune Diseases | Primary Immune Deficiency | Immunological DiseaseUnited States
-
GlaxoSmithKlineCompleted
-
Malaghan Institute of Medical ResearchRecruitingLymphoma | Leukemia | Myeloma | Temperature Change, Body | Haematological MalignancyNew Zealand
-
GlaxoSmithKlineCompleted
-
Instituto Grifols, S.A.CompletedPrimary Immune Deficiency DiseaseUnited States
-
Christchurch Clinical Studies Trust LtdMedtronicUnknownType1diabetesNew Zealand
-
Therapure Biopharma IncUnknownPrimary Immune Deficiency Diseases (PIDD)United States, Canada
-
Cairo UniversityRecruitingBreast Cancer | Diet, Healthy | Immune DeficiencyEgypt
-
AbbVieRecruitingHuman Immuno-deficiency Virus (HIV) DiseaseUnited States, Puerto Rico, Japan, Spain, Germany, Canada, Belgium, France
-
Zenas BioPharma (USA), LLCActive, not recruitingRheumatoid Arthritis | Healthy VolunteersNew Zealand, Australia
-
CSL BehringCompletedPrimary Immune DeficiencyUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia, New Zealand
-
CSL LimitedCompleted
-
Baxalta now part of ShireCompletedAlpha 1-Antitrypsin DeficiencyNew Zealand, Australia
-
Innate ImmunotherapeuticsNational Multiple Sclerosis Society; Primorus Clinical TrialsCompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisNew Zealand
-
Malaghan Institute of Medical ResearchWellington Zhaotai Therapies Limited (WZTL)RecruitingMantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Lymphomas Non-Hodgkin's B-Cell | Transformed Follicular Lymphoma (TFL) | Primary Mediastinal B-cell Lymphoma (PMBCL)New Zealand
-
GlaxoSmithKlineCompleted
-
Baxalta now part of ShireBaxter Healthcare, Ltd. (New Zealand), Baxter Healthcare Pty. Ltd. (Australia)CompletedAlpha 1-Antitrypsin DeficiencyAustralia, New Zealand
-
Progenics Pharmaceuticals, Inc.CompletedHIV Infections | Acquired Immune Deficiency SyndromeUnited States
-
Rutgers, The State University of New JerseyRecruiting
-
Lederle LaboratoriesCompleted